Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial (vol 23, pg P183, 2023)

被引：0
|
作者：
Khoo, S. H.
FitzGerald, R.
Saunders, G.
机构：
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E1 / E1
页数：1
相关论文
共 50 条
  • [1] Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial
    Khoo, Saye H.
    FitzGerald, Richard
    Saunders, Geoffrey
    Middleton, Calley
    Ahmad, Shazaad
    Edwards, Christopher J.
    Hadjiyiannakis, Dennis
    Walker, Lauren
    Lyon, Rebecca
    Shaw, Victoria
    Mozgunov, Pavel
    Periselneris, Jimstan
    Woods, Christie
    Bullock, Katie
    Hale, Colin
    Reynolds, Helen
    Downs, Nichola
    Ewings, Sean
    Buadi, Amanda
    Cameron, David
    Edwards, Thomas
    Knox, Emma
    Donovan-Banfield, I'ah
    Greenhalf, William
    Chiong, Justin
    Lavelle-Langham, Lara
    Jacobs, Michael
    Northey, Josh
    Painter, Wendy
    Holman, Wayne
    Lalloo, David G.
    Tetlow, Michelle
    Hiscox, Julian A.
    Jaki, Thomas
    Fletcher, Thomas
    Griffiths, Gareth
    LANCET INFECTIOUS DISEASES, 2023, 23 (02): : 183 - 195
  • [2] Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
    Xia, Shengli
    Zhang, Yuntao
    Wang, Yanxia
    Wang, Hui
    Yang, Yunkai
    Gao, George Fu
    Tan, Wenjie
    Wu, Guizhen
    Xu, Miao
    Lou, Zhiyong
    Huang, Weijin
    Xu, Wenbo
    Huang, Baoying
    Wang, Huijuan
    Wang, Wei
    Zhang, Wei
    Li, Na
    Xie, Zhiqiang
    Ding, Ling
    You, Wangyang
    Zhao, Yuxiu
    Yang, Xuqin
    Liu, Yang
    Wang, Qian
    Huang, Lili
    Yang, Yongli
    Xu, Guangxue
    Luo, Bojian
    Wang, Wenling
    Liu, Peipei
    Guo, Wanshen
    Yang, Xiaoming
    LANCET INFECTIOUS DISEASES, 2021, 21 (01): : 39 - 51
  • [3] Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
    Chen, Gui-Ling
    Li, Xiao-Feng
    Dai, Xia-Hong
    Li, Nan
    Cheng, Meng-Li
    Huang, Zhen
    Shen, Jian
    Ge, Yu-Hua
    Shen, Zhen-Wei
    Deng, Yong-Qiang
    Yang, Shu-Yuan
    Zhao, Hui
    Zhang, Na-Na
    Zhang, Yi-Fei
    Wei, Ling
    Wu, Kai-Qi
    Zhu, Meng-Fei
    Peng, Cong-Gao
    Jiang, Qi
    Cao, Shou-Chun
    Li, Yu-Hua
    Zhao, Dan-Hua
    Wu, Xiao-Hong
    Ni, Ling
    Shen, Hua-Hao
    Dong, Chen
    Ying, Bo
    Sheng, Guo-Ping
    Qin, Cheng-Feng
    Gao, Hai-Nv
    Li, Lan-Juan
    LANCET MICROBE, 2022, 3 (03): : E193 - E202
  • [4] TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial
    Burant, Charles F.
    Viswanathan, Prabhakar
    Marcinak, John
    Cao, Charlie
    Vakilynejad, Majid
    Xie, Benhuai
    Leifke, Eckhard
    LANCET, 2012, 379 (9824): : 1403 - 1411
  • [5] Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
    Kordes, Sil
    Pollak, Michael N.
    Zwinderman, Aeilko H.
    Mathot, Ron A.
    Weterman, Mariette J.
    Beeker, Aart
    Punt, Cornelis J.
    Richel, Dick J.
    Wilmink, Johanna W.
    LANCET ONCOLOGY, 2015, 16 (07): : 839 - 847
  • [6] Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial
    Kappos, Ludwig
    Hartung, Hans-Peter
    Freedman, Mark S.
    Boyko, Alexey
    Radue, Ernst Wilhelm
    Mikol, Daniel D.
    Lamarine, Marc
    Hyvert, Yann
    Freudensprung, Ulrich
    Plitz, Thomas
    van Beek, Johan
    LANCET NEUROLOGY, 2014, 13 (04): : 353 - 363
  • [7] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
    Wallace, Daniel J.
    Furie, Richard A.
    Tanaka, Yoshiya
    Kalunian, Kenneth C.
    Mosca, Marta
    Petri, Michelle A.
    Doerner, Thomas
    Cardiel, Mario H.
    Bruce, Ian N.
    Gomez, Elisa
    Carmack, Tara
    DeLozier, Amy M.
    Janes, Jonathan M.
    Linnik, Matthew D.
    de Bono, Stephanie
    Silk, Maria E.
    Hoffman, Robert W.
    LANCET, 2018, 392 (10143): : 222 - 231
  • [8] Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
    Monk, Phillip D.
    Marsden, Richard J.
    Tear, Victoria J.
    Brookes, Jody
    Batten, Toby N.
    Mankowski, Marcin
    Gabbay, Felicity J.
    Davies, Donna E.
    Holgate, Stephen T.
    Ho, Ling-Pei
    Clark, Tristan
    Djukanovic, Ratko
    Wilkinson, Tom M. A.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : 196 - 206
  • [9] A randomized, double-blind, placebo-controlled phase 1 and phase 2 clinical trial to evaluate efficacy and safety of a SARS-CoV-2 vaccine SCoK in adults
    Luo, Deyan
    Pan, Hongxing
    He, Peng
    Yang, Xiaolan
    Li, Tao
    Ning, Nianzhi
    Fang, Xin
    Yu, Wenjing
    Wei, Mingwei
    Gao, Hui
    Wang, Xin
    Gu, Hongjing
    Mei, Maodong
    Li, Xinwang
    Zhang, Liangyan
    Li, Deyu
    Gao, Chunrun
    Gao, Jinbang
    Fei, Guoqiang
    Li, Ying
    Yang, Yuguo
    Xu, Yi
    Wei, Wenjin
    Sun, Yansong
    Zhu, Fengcai
    Hu, Zhongyu
    Wang, Hui
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (09):
  • [10] Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
    Boxer, Adam L.
    Lang, Anthony E.
    Grossman, Murray
    Knopman, David S.
    Miller, Bruce L.
    Schneider, Lon S.
    Doody, Rachelle S.
    Lees, Andrew
    Golbe, Lawrence I.
    Williams, David R.
    Corvol, Jean-Cristophe
    Ludolph, Albert
    Burn, David
    Lorenzl, Stefan
    Litvan, Irene
    Roberson, Erik D.
    Hoeglinger, Guenter U.
    Koestler, Mary
    Jack, Clifford R., Jr.
    Van Deerlin, Viviana
    Randolph, Christopher
    Lobach, Iryna V.
    Heuer, Hilary W.
    Gozes, Illana
    Parker, Lesley
    Whitaker, Steve
    Hirman, Joe
    Stewart, Alistair J.
    Gold, Michael
    Morimoto, Bruce H.
    LANCET NEUROLOGY, 2014, 13 (07): : 676 - 685
12345